Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | XL495 |
| Synonyms | |
| Therapy Description |
XL495 inhibits PKMYT1, which potentially induces mitotic arrest and apoptosis in tumor cells and inhibits tumor growth (Cancer Res (2025) 85 (8_Supplement_1): 1733, NCI Drug Dictionary). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| XL495 | XL-495|XL 495 | PKMYT1 Inhibitor 4 | XL495 inhibits PKMYT1, which potentially induces mitotic arrest and apoptosis in tumor cells and inhibits tumor growth (Cancer Res (2025) 85 (8_Supplement_1): 1733, NCI Drug Dictionary). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT06630247 | Phase I | XL495 | A Dose-escalation, Dose-finding, and Expansion Study of XL495 in Participants With Locally Advanced or Metastatic Solid Tumors | Terminated | USA | 0 |